Ryva Mechanoporation System Platform Development
Cell Therapy Manufacturing Enabling Technology
Research/Process DevelopmentActive
Key Facts
Indication
Cell Therapy Manufacturing Enabling Technology
Phase
Research/Process Development
Status
Active
Company
About CellFE
CellFE is a private, pre-revenue biotech company founded in 2017 and based in Alameda, California. It has developed the Ryva™ Mechanoporation System, a benchtop platform that uses microfluidic physical force to deliver genetic payloads into cells, aiming to replace viral vectors and electroporation. The technology promises high cell viability, scalability, and faster manufacturing times, targeting the significant cost and scalability challenges in the cell therapy industry. The company is led by a team with deep expertise in engineering and microfluidics and is backed by a $22M Series A round led by M Ventures.
View full company profileOther Cell Therapy Manufacturing Enabling Technology Drugs
| Drug | Company | Phase |
|---|---|---|
| Automated hiPSC Expansion | Unicorn Biotechnologies | Commercial/Application |
| Automated Cardiomyocyte Differentiation | Unicorn Biotechnologies | Commercial/Application |